Lotrel Capsule
Product Images NDC 0078-0406
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lotrel (NDC 0078-0406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Amlodipine Besylate Structural Formula (Lotrel 02)
Principal Display Panel Ndc 0078-0405-05 Lotrel® 5 mg */10 mg Amlodipine And Benazepril Hydrochloride Capsules *each Capsule Contains 6.9 mg Of Amlodipine Besylate 100 Capsules Rx Only Novartis (Lotrel 03)
Principal Display Panel Ndc 0078-0406-05 Lotrel® 5 mg*/20 mg Amlodipine And Benazepril Hydrochloride Capsules *each Capsule Contains 6.9 mg Of Amlodipine Besylate 100 Capsules Rx Only Novartis (Lotrel 04)
Principal Display Panel Ndc 0078-0364-05 Lotrel® 10 mg*/20 mg Amlodipine And Benazepril Hydrochloride Capsules *each Capsule Contains 13.9 mg Of Amlodipine Besylate 100 Capsules Rx Only Novartis (Lotrel 05)
Principal Display Panel Ndc 0078-0379-05 Lotrel® 10 mg*/40 mg Amlodipine And Benazepril Hydrochloride Capsules *each Capsule Contains 13.9 mg Of Amlodipine Besylate 100 Capsules Rx Only Novartis (Lotrel 06)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.